The rapid spread of COVID-19, which has infected more than eight million people across the planet and led to over 400,000 deaths, presents the world with an unprecedented health and economic challenge, especially to the frontline medical professionals risking their lives taking care of COVID-19 patients. More
Anglo-Swedish drug maker AstraZeneca continues to see a rise in sales of its drugs in China – the world’s second largest pharmaceutical market. At the same time, it is also looking to boost scientific research in the country. It hopes that the jurisdictional obstacles in the fledgling Greater Bay Area (GBA) project can be overcome to allow it to use the region’s massive pool of patients to conduct clinical trials, which it hopes will take its research and development to new levels. More
Viewed as very much a new frontier, the defining characteristics of the biotechnology sector appear to be the sheer breadth of its potential applications and the need for in-depth specialisation to make good on any of its myriad possibilities. More
Biotech start-up Phase Scientific – which has the backing of, among others, the Bill and Melinda Gates Foundation – has chosen Hong Kong over the US as the base for its global headquarters. The company, founded in the US six years ago, began operating in the city in 2017 and aims to take its cutting-edge medical diagnostic tools into the mainland Chinese market by capitalising on the thirst for innovation and new technology in the Greater Bay Area. More
In the 19th century, Hong Kong made an indelible mark on the world of medicine – it was here that the lifecycle of one of humanity’s greatest scourges, malaria, was discovered, opening the way to control and cure.
A Hong Kong Pavilion will be featured at BIO International Convention, participating companies include biotech, biopharmaceutical and technology transfer offices from tertiary education institutions. More